Related references
Note: Only part of the references are listed.Epithelial ovarian cancer risk: A review of the current genetic landscape
Nicola Flaum et al.
CLINICAL GENETICS (2020)
Nanodrug Delivery Systems for the Treatment of Ovarian Cancer
Jonathan M. Pantshwa et al.
CANCERS (2020)
Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition
Lin Deng et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
Inflammatory arthritis: a unique presentation of human anaplasmosis
Lara El Khoury et al.
CLINICAL RHEUMATOLOGY (2019)
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor
Allison Gartung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
COX-2 inhibition by celecoxib in epithelial ovarian cancer attenuates E-cadherin suppression through reduced Snail nuclear translocation
Yan-Ping Wang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2018)
Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
Yen-Hsiu Yeh et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer
Heidi Kemilainen et al.
ONCOLOGY (2018)
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
Josh W. DiGiacomo et al.
TARGETED ONCOLOGY (2018)
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Jillian R. Hufgard Wendel et al.
CANCERS (2018)
Ovarian cancer: epidemiology and risk factors
Carlo La Vecchia
EUROPEAN JOURNAL OF CANCER PREVENTION (2017)
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
Laura D'Ignazio et al.
BIOMEDICINES (2017)
Multifaceted link between cancer and inflammation
Gautam Sethi et al.
BIOSCIENCE REPORTS (2012)
Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene
Akiko Horiuchi et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies
IH Roland et al.
CANCER (2003)
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
G Gasparini et al.
LANCET ONCOLOGY (2003)
The function of COX-2 in human ovarian carcinoma
R Agarwal
AMERICAN JOURNAL OF PATHOLOGY (2003)
Share Paper
